Comparison of SpO₂ (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

الموضوعات:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

الموضوعات:

Unmatched kernel density function diagram. حسب Yanling Li (269030)

الموضوعات:

(A) Mobility rate, (B) Explored areas, (5C) Immobility time, (D) Frozen events for hole board test. حسب Hammad Ismail (4227988)

Dataset (Figs 2–5). حسب Xianyong Wang (22601067)

"…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …"

Schematic diagram of soil sample collection. حسب Xianyong Wang (22601067)

"…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …"

Changes in the neutrophil count. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Changes in the platelet count. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Changes in the white blood cell count. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Changes in the hemoglobin. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

WBC and ANC on day 7 post-chemotherapy. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

General clinical data of 88 patients with NPC. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

CONSORT participant flow diagram. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

S4 File - حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Source data - حسب Desheng Xie (21439869)

الموضوعات:

Innovation and night light in large and small cities. حسب Saul Estrin (8629173)

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. حسب Hala Tamim El Jarkass (16625309)

الموضوعات:

Significant Wilcoxon test results of the Task 1 Nasa TLX data, differences between feedback ON and OFF. حسب Mucahit Gemici (21519313)

Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance حسب Yifan Liu (219681)

الموضوعات:

Probability of Cost-Effectiveness Across CET. حسب Yiping An (20609789)

الموضوعات: